The most common first-time medication was semaglutide (brand names Ozempic and Wegovy as ADM and AOM, respectively)
Last week, the FDA accused Novo Nordisk of failing to develop proper procedures for reporting on side effects related to these popular diabetes and weight loss drugs
Urinary neutrophil gelatinase associated lipocalins (NGALs) predict acute kidney injury post liver transplant
Common FAQs about Semaglutide Timing 1
The effectiveness of these anti-diabetic drugs in HF patients has been clearly established
The results from a large retrospective cohort study of 81,573 patients with T2D in the United Kingdom between 2004 and 2006, with follow-up until 2011, showed that the median time to intensification with insulin was 7.1, 6.1, and 6.0 years for those taking 1, 2, or 3 oral glucose-lowering agents, and mean glycated hemoglobin (HbA1c) was 8.7, 9.1, and 9.7%, respectively [19]